Delcath Systems Inc 's (DCTH) Outlook - CSIMarket
CSIMarket
 
Delcath Systems Inc   (NASDAQ: DCTH)
 



  Delcath Systems Inc Outlook

On January 13 2025 the Delcath Systems Inc provided following guidance

nnDelcath Systems Inc. Provides Preliminary Financial Results for Fourth Quarter and Full Year 2024nn

QUEENSBURY, N.Y. - Delcath Systems, Inc. (Nasdaq: DCTH), an innovative interventional oncology company dedicated to the treatment of primary and metastatic liver cancers, has released its preliminary financial results for the fourth quarter and the entire fiscal year ending December 31, 2024. According to the estimates, the company anticipates generating approximately $15.1 million in revenue for the fourth quarter, with full-year revenue projected at around $37.2 million.

These figures represent a significant indicator of the company's ongoing efforts to address the challenges posed by liver cancer, further underscoring Delcath's commitment to advancing its treatment methodologies. The preliminary revenue figures reflect the company’s strategic initiatives and operational performance over the past year as it continues to carve out its niche in the oncology market specifically focused on liver cancer therapies.

The anticipated financial outcomes, while still unaudited, demonstrate Delcath's continued progress and the potential for growth in the interventional oncology sector. Investors and stakeholders will be closely monitoring the finalized results, which are expected to be released in the coming weeks, as they reflect the overall impact of the company’s innovations and market developments.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.